Hypoxic glioma-derived exosomal miR-25-3p promotes macrophage M2 polarization by activating the PI3K-AKT-mTOR signaling pathway

被引:3
|
作者
Xue, Zhiwei [1 ,2 ]
Liu, Junzhi [1 ,2 ]
Xing, Wenchen [1 ,2 ]
Mu, Feiyu [1 ,2 ]
Wu, Yanzhao [1 ,2 ]
Zhao, Jiangli [1 ,2 ]
Liu, Xuchen [1 ,2 ]
Wang, Donghai [1 ,2 ,5 ]
Wang, Jian [1 ,2 ,6 ]
Li, Xingang [1 ,2 ,3 ,4 ]
Wang, Jiwei [1 ,2 ]
Huang, Bin [1 ,2 ,3 ,4 ,5 ]
机构
[1] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurosurg, Jinan, Peoples R China
[2] Shandong Univ, Inst Brain & Brain Inspired Sci, Jinan, Peoples R China
[3] Jinan Microecol Biomed Shandong Lab, Jinan, Peoples R China
[4] Shandong Key Lab Brain Hlth & Funct Remodeling, Jinan, Peoples R China
[5] Shandong Univ, Qilu Hosp, Dezhou Hosp, Dept Neurosurg, Dezhou, Peoples R China
[6] Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway
关键词
Glioma; Exosomes; miRNAs; PHLPP2; AKT-mTOR; GLIOBLASTOMA STEM-CELLS; EXTRACELLULAR VESICLES; M2-LIKE POLARIZATION; MESSENGER-RNAS; IMMUNE CELLS; CANCER; PROLIFERATION; THERAPEUTICS; TEMOZOLOMIDE; PROGRESSION;
D O I
10.1186/s12951-024-02888-5
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
BackgroundExosomes (EXO) play crucial roles in intercellular communication and glioma microenvironment modulation. Tumor-associated macrophages are more likely to become M2-like type macrophages in the immunosuppressive microenvironment. Here, we aimed to investigate the effects and molecular mechanisms of hypoxic glioma-derived exosomes mediated M2-like macrophage polarization.MethodsHighly expressed miRNAs in exosomes derived from glioma cells cultured under hypoxia condition compared to normoxic condition were identified through microRNA sequencing. The polarization status of macrophages was determined using qRT-PCR, Western blotting, flow cytometry, and immunohistochemistry. By using RNA-seq, we aimed to identify the downstream target genes regulated by miR-25-3p in macrophages and investigate the mechanistic pathways through which it exerts its effects. The proliferation and migration capabilities of glioma cells were assessed through EdU, Transwell assays, and in vivo experiments.ResultsWe found that miR-25-3p was upregulated in the exosomes derived from hypoxic glioma cells and can be transferred to the macrophage. In macrophages, miR-25-3p downregulates the expression of PHLPP2, thereby activating the PI3K-AKT-mTOR signaling pathway, ultimately leading to macrophage M2 polarization. As part of a feedback loop, M2-polarized macrophages can, in turn, promote malignant glioma progression.ConclusionOur study reveals that miR-25-3p from hypoxic glioma cells is delivered to macrophages via exosomes as a mediator, promoting M2 polarization of macrophages through the miR-25-3p/PHLPP2/PI3K-AKT signaling pathway. This study suggests that targeted interventions to modulate miR-25-3p expression, transmission, or inhibition of PI3K-AKT pathway activation can disrupt the immune-suppressive microenvironment, providing a novel approach for immunotherapy in gliomas.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Tumour-derived exosomal miR-205 promotes ovarian cancer cell progression through M2 macrophage polarization via the PI3K/Akt/mTOR pathway
    He, Liuqing
    Chen, Quan
    Wu, Xiaoying
    JOURNAL OF OVARIAN RESEARCH, 2025, 18 (01)
  • [2] M2 macrophage-derived exosomal microRNAs inhibit cell migration and invasion in gliomas through PI3K/AKT/mTOR signaling pathway
    Yao, Jie
    Wang, Zefen
    Cheng, Yong
    Ma, Chao
    Zhong, Yahua
    Xiao, Yilei
    Gao, Xu
    Li, Zhiqiang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [3] M2 macrophage-derived exosomal microRNAs inhibit cell migration and invasion in gliomas through PI3K/AKT/mTOR signaling pathway
    Jie Yao
    Zefen Wang
    Yong Cheng
    Chao Ma
    Yahua Zhong
    Yilei Xiao
    Xu Gao
    Zhiqiang Li
    Journal of Translational Medicine, 19
  • [4] Exosomal miR-301a-3p from esophageal squamous cell carcinoma cells promotes angiogenesis by inducing M2 polarization of macrophages via the PTEN/PI3K/AKT signaling pathway
    Shou, Yuwei
    Wang, Xiaoqian
    Chen, Chao
    Liang, Yinghao
    Yang, Chenbo
    Xiao, Qiankun
    Li, Hui
    Wang, Shuaiyuan
    Shu, Jiao
    Tian, Xiangyu
    Chen, Kuisheng
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [5] Upregulation of exosomal integrin β4 causes osteosarcoma cell proliferation via the PI3K-Akt-mTOR signaling pathway
    Wang, Qianrong
    Shi, Zheughua
    Zhang, Hongmei
    Liu, Wenchao
    Yu, Zhicao
    Zhau, Qiong
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (05) : 1209 - 1220
  • [6] LMO4 promotes the invasion and proliferation of gastric cancer by activating PI3K-Akt-mTOR signaling
    Wang, Ning
    Dong, Qing
    Zhou, Xiao-Na
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (10): : 6534 - 6543
  • [7] JAML overexpressed in colorectal cancer promotes tumour proliferation by activating the PI3K-AKT-mTOR signalling pathway
    Fang, Yuying
    Liu, Yanan
    Dong, Zhilin
    Zhao, Xinchao
    Zhang, Mingyan
    Zheng, Yawen
    Yang, Chunsheng
    Wang, Yufeng
    Liu, Ning
    Yan, Peng
    Ma, Yuan
    Yang, Fei
    Zheng, Yan
    Zhang, Wencheng
    Yang, Jianmin
    Sun, Meili
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [8] Exosomal miR-301a-3p from esophageal squamous cell carcinoma cells promotes angiogenesis by inducing M2 polarization of macrophages via the PTEN/PI3K/AKT signaling pathway
    Yuwei Shou
    Xiaoqian Wang
    Chao Chen
    Yinghao Liang
    Chenbo Yang
    Qiankun Xiao
    Hui Li
    Shuaiyuan Wang
    Jiao Shu
    Xiangyu Tian
    Kuisheng Chen
    Cancer Cell International, 22
  • [9] CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway
    Jiang, Chao
    Ma, Zhenghong
    Zhang, Guoan
    Yang, Xigui
    Du, Qin
    Wang, Weibo
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10135 - 10143
  • [10] MiR-92a-3p Promotes the Malignant Progression of Hepatocellular Carcinoma by Mediating the PI3K/AKT/mTOR Signaling Pathway
    Wang, Libing
    Cui, Mingxin
    Qu, Fengzhi
    Cheng, Daming
    Yu, Jingkun
    Tang, Zhaoyuan
    Cheng, Ling
    Wei, Yanbing
    Wu, Xiaotang
    Liu, Xiaogang
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (29) : 3244 - 3250